General Announcement::Updates

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
21-Jan-2020 20:47:26
Status
New
Announcement Sub Title
Updates
Announcement Reference
SG200121OTHRCQQQ
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
21/01/2020 18:00:00
Description (Please provide a detailed description of the event in the box below)
This is to inform you that the Board of Glenmark Pharmaceuticals Limited (the "Company") at its meeting held today approved the transaction, the details of which are mentioned in the Annexure A.

You are requested to kindly take note of the same.

Thanking you,

Attachments

SGX Announcement.pdf
Total size =1690K